Skip to content
Disclosery

ORBIMED ADVISORS LLC: KRYS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on KRYS, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 83,200 KRYS shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 83,200 shares
    Change vs previous 13F +14,100 shares

    0.59% of the 13F portfolio, value $30,922,944.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 69,100 shares
    Change vs previous 13F -50,700 shares

    0.39% of the 13F portfolio, value $17,849,912.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 119,800 shares
    Change vs previous 13F +17,055 shares

    0.6% of the 13F portfolio, value $29,535,492.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 102,745 shares
    Change vs previous 13F +93,545 shares

    0.43% of the 13F portfolio, value $18,137,575.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 9,200 shares
    Change vs previous 13F -14,300 shares

    0.03% of the 13F portfolio, value $1,264,632.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 23,500 shares
    Change vs previous 13F 0 shares

    0.1% of the 13F portfolio, value $4,237,050.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 23,500 shares
    Change vs previous 13F 0 shares

    0.08% of the 13F portfolio, value $3,681,510.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 23,500 shares
    Change vs previous 13F not available

    0.08% of the 13F portfolio, value $4,277,705.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).